Single vs. multiple fraction regimens for palliative radiotherapy treatment of multiple myeloma: A prospective randomised study

• Published in: Strahlentherapie und Onkologie 2017-09, Vol.193 (9), p.742-749
• Main Authors: Rudzianskiene, Milda, Inciura, Arturas, Gerbutavicius, Rolandas, Rudzianskas, Viktoras, Macas, Andrius, Simoliuniene, Renata, Dambrauskiene, Ruta, Kiavialaitis, Greta Emilia, Juozaityte, Elona
• Format: Article
• Language: English
• Subjects: Analgesics; Hemoglobin; Medicine; Medicine & Public Health; Multiple myeloma; Oncology; Original; Original Article; Pain; Patients; Radiation therapy; Radiographs; Radiotherapy
• ISSN: 0179-7158; 1439-099X
• DOI: 10.1007/s00066-017-1154-5

Purpose To compare the impact of a single fraction (8 Gy × 1 fraction) and multifraction (3 Gy × 10 fractions) radiotherapy regimens on pain relief, recalcification and the quality of life (QoL) in patients with bone destructions due to multiple myeloma (MM). Patients and methods In all, 101 patients were included in a randomised prospective clinical trial: 58 patients were included in the control arm (3 Gy × 10 fractions) and 43 patients into the experimental arm (8 Gy × 1 fraction). The response rate was defined according to the International Consensus on Palliative Radiotherapy criteria. Recalcification was evaluated with radiographs. QoL questionnaires were completed before and 4 weeks after treatment. Results Pain relief was obtained in 81/101 patients (80.2%): complete response in 56 (69%) and partial in 25 patients (30.9%). No significant differences were observed in analgesic response between the groups. Significant factors for pain relief were female gender, age under 65, IgG MM type, presence of recalcification at the irradiated site. Recalcification was found in 32/101 patients (33.7%): complete in 17 (53.2%) and partial in 15 (46.2%). No significant differences were observed in recalcification between the groups. Significant factors for recalcification were Karnofsky index ≥ 60%, haemoglobin level ≤ 80 g/dl, MM stage II and analgesic response at the irradiated site. The QoL after radiotherapy was improved in the control group. Conclusion The same analgesic and recalcification response was observed using two different radiotherapy regimens. Higher doses should be used to achieve a better QoL.